PapersPMID:41177307
Effects of carnitine supplementation on glycemic markers in women with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials.
- findings
- 2
- compound
- 1
- endpoints
- 2
(R)-carnitine- Study, every finding
- meta-analysis
- Population, every finding
- Women with overweight or obesity in eight studies (nine randomized trial arms), versus placebo
What moved
How to read these marks →“Carnitine supplementation significantly reduced fasting blood sugar (FBS; WMD -2.93 mg/dL, 95 % CI -5.20 to -0.65), fasting insulin (WMD -3.54 μU/mL, 95 % CI -7.00 to -0.07), and HOMA-IR (WMD -0.69, 95 % CI -1.26 to -0.13), but had no significant effect on QUICKI.”
- Decreases fasting blood glucose
very limited
- Effect
- −2.93 mean difference, 95% CI −5.2 to −0.65
- Decreases HOMA-IR
very limited
- Effect
- −0.69 mean difference, 95% CI −1.26 to −0.13
Study record
- Design
- meta-analysis
- Species
- human
- Population
- women with overweight or obesity in randomized controlled trials of carnitine supplementation
- Participants
- not reported
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 6